Past 10 year's financial track record analysis by Moneyworks4me indicates that Star Health and Allied Insurance Company Ltd is a good quality company.
The key valuation ratios of Star Health and Allied Insurance Company Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Star Health and Allied Insurance Company Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -84.5% | 54.4% | 20.5% | 17.1% | 20.5% | 22.9% | -49% | -31% | 14.8% | 17.8% | - |
| Value Creation Index ⓘ | -8.5 | 3.8 | 0.8 | 0.5 | 0.8 | 1.0 | -5.4 | -3.8 | 0.3 | 0.6 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | -3.9 | 3.5 | 2.6 | 3.7 | 4 | 5.4 | -19.8 | -18.1 | 10.6 | 14.4 | 14.7 |
| YoY Gr. | - | NA | -26.6% | 44% | 8% | 33.3% | -468.9% | NA | NA | 35.8% | - |
| BVPS (₹) ⓘ | 3.9 | 9.3 | 17.3 | 21.1 | 25.1 | 38.8 | 63.9 | 78.7 | 93.4 | 108.3 | 115.9 |
| Adj Net Profit ⓘ | -140 | 137 | 118 | 170 | 183 | 263 | -1,086 | -1,041 | 619 | 845 | 862 |
| Cash Flow from Ops. ⓘ | 147 | 126 | 321 | 557 | 776 | 647 | 890 | 55.6 | 1,276 | 1,310 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0.4 | 0.4 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | NA | ||||
| Adj EPS ⓘ | NA | 29.1% | NA | 35.8% | ||||
| BVPSⓘ | 44.6% | 34% | 19.3% | 16% | ||||
| Share Price | - | - | - | -19% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.8 | 14.4 | - |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116 |
Return on Equity has increased versus last 3 years average to 13.10%
Sales growth is good in last 4 quarters at 15.66%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 14.7 | - |
| TTM Sales (₹ Cr.) | 13,913 | - |
| BVPS (₹.) ⓘ | 115.9 | - |
| Reserves (₹ Cr.) ⓘ | 6,217 | - |
| P/BV ⓘ | 3.99 | - |
| PE ⓘ | 31.46 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 452.45 / 647.65 |
| All Time Low / High (₹) | 451.10 / 940.00 |
| Market Cap (₹ Cr.) | 27,118 |
| Equity (₹ Cr.) | 586.9 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 21 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income From Investments | 9 | 18 | 38 | 59 | 80 | 124 | 173 | 313 | 333 | 443 |
| Other Income ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 6 | 4 |
| Expenses | 2 | 130 | 17 | 26 | 38 | 32 | 104 | 133 | 217 | 47 |
| Profit Before Tax | -140 | 137 | 118 | 171 | 267 | 406 | -1,446 | -1,397 | 826 | 1,129 |
| Tax ⓘ | 0 | 0 | 0 | 1 | 84 | 143 | -360 | -356 | 208 | 284 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -140 | 137 | 118 | 170 | 183 | 263 | -1,086 | -1,041 | 619 | 845 |
| Adjusted EPS (₹) | -3.87 | 3.53 | 2.59 | 3.73 | 4.03 | 5.37 | -19.81 | -18.08 | 10.63 | 14.44 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Share Capital ⓘ | 362 | 387 | 456 | 456 | 456 | 491 | 548 | 576 | 582 | 585 |
| Reserve and Surplus | -220 | -27 | 334 | 504 | 687 | 1,413 | 2,951 | 3,953 | 4,848 | 5,754 |
| Fair Value A/C | 0 | 0 | 0 | 0 | 0 | 1 | -3 | 11 | 9 | 42 |
| Borrowings ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Policy Holders Fund | 0 | 0 | 0 | 0 | 0 | 2 | -4 | 16 | 14 | 61 |
| Funds For Appropriations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities ⓘ | 142 | 360 | 789 | 1,210 | 1,743 | 2,157 | 3,742 | 5,351 | 5,927 | 6,915 |
Assets | ||||||||||
| Investment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Net block | 46 | 62 | 77 | 92 | 85 | 90 | 80 | 113 | 101 | 159 |
| Total Assets ⓘ | 142 | 360 | 789 | 1,210 | 1,743 | 2,157 | 3,742 | 5,351 | 5,927 | 6,915 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 147 | 126 | 321 | 557 | 776 | 647 | 890 | 56 | 1,276 | 1,310 |
| PBT ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjustment ⓘ | 139 | 130 | 358 | 497 | 816 | 1,618 | 2,219 | 1,778 | 3,331 | 3,771 |
| Changes in Working Capital ⓘ | 11 | -0 | 0 | -37 | -27 | -11 | -13 | -26 | -20 | -35 |
| Tax Paid ⓘ | -2 | -4 | -36 | 97 | -12 | -960 | -1,316 | -1,696 | -2,035 | -2,426 |
| Cash Flow From Investing Activity ⓘ | -216 | -192 | -497 | -663 | -731 | -1,006 | -2,418 | -3,786 | -1,097 | -1,177 |
| Capex | -17 | -24 | -38 | -36 | -31 | -34 | -46 | -63 | -47 | -123 |
| Net Investments | -237 | -227 | -543 | -759 | -881 | -1,233 | -2,741 | -4,387 | -1,816 | -2,031 |
| Others ⓘ | 39 | 59 | 85 | 132 | 180 | 261 | 369 | 664 | 766 | 977 |
| Cash Flow From Financing Activityⓘ | 92 | 81 | 310 | 249 | 333 | 122 | 2,613 | 2,509 | -268 | 23 |
| Net Proceeds from Shares ⓘ | 92 | 81 | 310 | 0 | 350 | 147 | 2,645 | 2,095 | 61 | 64 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | 0 | -17 | -26 | -26 | -27 | -74 | -41 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0 | 0 | 0 | 249 | 0 | 0 | -6 | 441 | -254 | 0 |
| Net Cash Flow ⓘ | 24 | 14 | 134 | 143 | 379 | -237 | 1,086 | -1,221 | -89 | 156 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | ||||||||||
| ROCE (%) | ||||||||||
| Asset Turnover Ratio | 6.14 | 6.03 | 3.33 | 2.74 | 2.48 | 2.4 | 1.57 | 2.16 | 2 | 2.01 |
| PAT to CFO Conversion(x) | N/A | 0.92 | 2.72 | 3.28 | 4.24 | 2.46 | N/A | N/A | 2.06 | 1.55 | Working Capital Days |
| Receivable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Star Health and Allied Insurance Company is and continues to be the largest private health insurer in India. The company offers a range of flexible and comprehensive coverage options primarily for retail health, group health, personal accident and overseas travel. Its products target a variety of customer segments, including individuals, families, students, senior citizens, as well as persons with preexisting medical conditions across the broader middle market customer segment. Its products include family floater products, in which the sum insured covers the entire family on the payment of a single annual premium; individual products, which are tailored to the needs of the individual; and specialized products, which focus on customers with pre-existing conditions after taking into account the associated risks. It developed these specialized products through its innovation-driven product development process and analysis of market demand and coverage gaps using its market leading claims processing experience of approximately 6.7 million claims processed since its inception until September 30, 2021. It distributes its health insurance policies primarily through individual agents.
The company has invested in advanced technologies to develop a flexible and integrated information technology platform across its business processes, including omni-channel applications, such as its agent application, STAR ATOM, which assists agents to complete the policy sales process remotely in an effective and efficient manner, and its customer self-service application, STAR POWER, which enables it to deliver, in a consistent and personalized way, a customer experience that meets customers' insurance needs through a seemingly single channel regardless of customer entry points. It has also actively focused on streamlining the underwriting and claims processes for its customers through its proprietary information systems that it has developed in-house.
Business area of the company
The company is providing sterling services in health, personal accident and overseas travel insurance etc. It has excellent products to cater everybody, be it individuals, families or corporates. It work directly as well as through various channels like agents, brokers, online etc.
Awards, accreditations and recognitions
Major events and milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
FREE Become a savvy and confident
stock investor.
Hurry, limited to the first 10 users today!
Download APP
